Trial Profile
Phase IIa proof-of-principle study for the induction treatment of autoimmune hepatitis using infliximab AIH-MAB
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Jan 2018
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Autoimmune hepatitis
- Focus Therapeutic Use
- Acronyms AIH-MAB
- 12 Jan 2018 New trial record